Top Quality Raloxifene hydrochloride Anti Estrogen Steroids
Schnelles Detail:
Produktname: Raloxifenhydrochlorid
CAS-Nr: 82640-04-8
MF: C28H28ClNO4S
MW: 510.04
Reinheit: 99%Mindest.
Aussehen: Schwach gelbes Pulver
Verwendung : Raloxifen ist ein selektiver Östrogenrezeptormodulator (SERM); wirkt sowohl im Brust- als auch im Uterusgewebe als Antiöstrogen, während es im Knochen östrogen wirkt. Kann gegen östrogenempfindliche Krebsarten wirksam sein.
Produktbeschreibung:
For bodybuilding purposes Adipex-P is often administered during the pre-contest phase of training. When taken in conjunction with all the pre-contest principles that would be employed anyway, i. e. Cardio and weight training exercise, behavioral modification, caloric restriction, increased protein consumption, usw., Adipex-P can be a great addition to the carbohydrate craving/depleted diet regimen.
The usual adult dose is one tablet (37.5 mg) daily, administered before breakfast or 1-2 hours after breakfast. Bodybuilder dosage recommendations are consistent with those of patients, and should be individualized to obtain an adequate response with the lowest effective dose. For some patients or bodybuilders half a tablet (18.75 mg) daily may be adequate, while others might take half a dose twice daily. Raloxifen ist ein selektiver Östrogenrezeptormodulator (SERM); wirkt sowohl im Brust- als auch im Uterusgewebe als Antiöstrogen, während es im Knochen östrogen wirkt. Kann gegen östrogenempfindliche Krebsarten wirksam sein.
Raloxifene Adverse reactions
Raloxifene may infrequently cause serious blood clots to form in the legs, lungs, or eyes. Other reactions experienced include leg swelling/pain, trouble breathing, chest pain, vision changes. Raloxifene is a teratogenic drug, i.e., can cause developmental abnormalities such as birth defects.
Black box warnings were added to the label of raloxifene in 2007 warning of increased risk of death due to stroke for postmenopausal women with documented coronary heart disease or at increased risk for major coronary events, as well as increased risks for deep vein thrombosis and pulmonary embolism.